Clinical pharmacokinetics, pharmacodynamics and metabolism of the novel matrix metalloproteinase inhibitor ABT-518

M. Crul, L.V. Beerepoot, E. Stokvis, J.S.P. Vermaat, H. Rosing, J.H. Beijnen, E.E. Voest, J.H.M. Schellens

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Number of pages	6
Journal	Cancer Chemotherapy and Pharmacology
Volume	50
Issue number	473-478
Publication status	Published - 2002

Cite this

@article{5077b266820d43fbb874b326c648f2b1,

title = "Clinical pharmacokinetics, pharmacodynamics and metabolism of the novel matrix metalloproteinase inhibitor ABT-518",

author = "M. Crul and L.V. Beerepoot and E. Stokvis and J.S.P. Vermaat and H. Rosing and J.H. Beijnen and E.E. Voest and J.H.M. Schellens",

year = "2002",

language = "Undefined/Unknown",

volume = "50",

journal = "Cancer Chemotherapy and Pharmacology",

issn = "0344-5704",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "473-478",

}

TY - JOUR

T1 - Clinical pharmacokinetics, pharmacodynamics and metabolism of the novel matrix metalloproteinase inhibitor ABT-518

AU - Crul, M.

AU - Beerepoot, L.V.

AU - Stokvis, E.

AU - Vermaat, J.S.P.

AU - Rosing, H.

AU - Beijnen, J.H.

AU - Voest, E.E.

AU - Schellens, J.H.M.

PY - 2002

Y1 - 2002

M3 - Article

SN - 0344-5704

VL - 50

JO - Cancer Chemotherapy and Pharmacology

JF - Cancer Chemotherapy and Pharmacology

IS - 473-478

ER -